Toxic Shock Syndrome (TSS): Treatment Protocol and Critical Care Management

Toxic Shock Syndrome (TSS) is a life-threatening toxin-mediated illness (TSST-1 from S. aureus; streptococcal pyrogenic exotoxins from S. pyogenes). Management requires rapid recognition, aggressive resuscitation, and source control.

1. Immediate Stabilization (ABCs)

• Airway protection (intubate if altered mental status).
• High-flow oxygen.
• Large-bore IV access ×2; aggressive fluid resuscitation (crystalloids 20–30 mL/kg boluses).
• Vasopressors (norepinephrine first-line) for refractory hypotension.

2. Antimicrobial Therapy

• Empiric IV antibiotics within 1 hour:
  • S. aureus coverage: Vancomycin 15–20 mg/kg IV q8–12h (covers MRSA) PLUS Clindamycin 900 mg IV q8h (inhibits toxin synthesis).
  • S. pyogenes coverage: Penicillin G 4M units IV q4h PLUS Clindamycin.
  • If polymicrobial (post-surgical, wound): Add gram-negative coverage (piperacillin-tazobactam, meropenem).
• De-escalate based on cultures/sensitivities.

3. Source Control

• Remove tampon, contraceptive device, nasal packing, or any foreign body.
• Surgical exploration/drainage of infected wounds, abscesses, necrotizing fasciitis.
• Debridement of necrotic tissue; amputation if limb-threatening.

4. Supportive Care

• ICU monitoring: hemodynamics, urine output, lactate, coagulation, electrolytes, ABGs.
• Renal replacement therapy for AKI.
• Mechanical ventilation for ARDS.
• IVIG 1–2 g/kg (adjunct for streptococcal TSS; consider for staphylococcal).
• Stress-dose steroids if adrenal insufficiency suspected.

5. Wound Care & Rehabilitation

• Daily wound assessment; advanced dressings.
• Physical/occupational therapy for deconditioning.

Key Prognostic Factors

• Time to antibiotics and source control.
• Age, comorbidities, organ failure count.
• Streptococcal TSS has higher mortality (~30–60%) than staphylococcal (~5–15%).

Early aggressive care saves lives. TSS is a medical emergency.